Clinical Trial Supply Chain Management
API & Bulk Drug Substance Shipment
Marken works with leading manufacturers to help ensure the quality and efficacy of Active Pharmaceutical Ingredients (API) and Bulk Drug Substance during shipment. Marken closely screens the supply chain for successful transport to your global sites adhering to stringent regulations and local governance in each country.
Related resources
Revolutionizing Patient-Centric Supply Chains to Improve Vaccine Access
7 February 2023
Global disruptions over the past several years have had an undeniable impact on the vaccine landscape, including research trends, risk…
Optimizing Storage and Distribution in an Era of Clinical Trial Transformation
4 January 2023
Strategic storage and distribution are pivotal pieces in the orchestration of delivering lifesaving treatments to patients throughout the entire pharmaceutical…
Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours
4 January 2023
The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…
Happy Holidays from Marken
21 December 2022
At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…
Marken Overcomes Multiple Obstacles To Successfully Deliver Critical Stem Cell Samples Across The Globe
9 December 2022
Stem cell samples require extremely tight 24-hour turnaround times in order to be modified and processed for critical cell therapy…
Decentralized Trial Logistics Requires Thoughtful Strategy: Marken
22 September 2021
Outsourcing Pharma and Marken President Ariette van Strien discuss the complexity of decentralized trials and considerations for crafting a strategic…
Fortifying Logistics With Technology for Decentralized Trials
11 August 2021
Contract Pharma and Wes Wheeler, President of UPS Healthcare, discuss the partnership between Marken and THREAD, a decentralized clinical trial…
What a Global Pandemic Taught Us About the Pharmaceutical Supply Chain
10 August 2021
The COVID-19 pandemic highlighted both the strengths and weaknesses of the pharmaceutical supply chain. In this article for peer-reviewed Journal…
Personalized Medicine Requires Complex Supply Chains: Marken
26 July 2021
Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved…
The Ultimate Patient-Centric Supply Chain
16 July 2021
From two-hour grocery delivery to telehealth visits, consumers have come to expect convenience, immediacy and personalization from everyday service providers….
Flexible Supply Chain Development: The Engine of Decentralized Trials
7 June 2021
The distribution structure is the engine that drives decentralized clinical trials (DCTs). Reliable, yet flexible storage, tracking and technology, among…
Evaluating a Clinical Supply Chain Partner to Meet Your Vaccine Trial Needs
23 April 2021
It is essential for pharmaceutical companies to evaluate many factors when choosing a clinical supply chain partner. With today’s global…
Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.
Login and quick links